Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen.
暂无分享,去创建一个
M. Takemura | M. Seishima | T. Takeuchi | H. Moriwaki | Tetsuya Yamada | T. Takami | H. Tsurumi | Naoe Goto | Takuro Matsumoto | Y. Shibata | Hiroshi Nakamura | Ryoko Mabuchi | Nobuhiko Nakamura